ESPR | Esperion Therapeutics Inc.
Quick infos Headquarters: Ann Arbor, Michigan, United States Trade prices Volume: Market Cap: 406.39M Prev closed: Open: 4.78 High: 5.02 Low: 4.62 52 week low: 3.28 52 week high: 32 Dividends: No Dividends Next ER: February 21, 2023 Before Market Opens
About the Company Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Earnings History Date EPS / Forecast Revenue / Forecast May 2, 2023 February 21, 2023 -0.76 / -0.8518.82M / 20.57MNovember 1, 2022 -0.81 / -0.9218.98M / 19.91MAugust 2, 2022 -1.05 / -0.928918.84M / 18.62MBeat! May 3, 2022 -0.93 / -1.0418.84M / 15.41MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 3, 2022 5.77 5.62 5.83
5.40
1.07M -1.7% Aug 2, 2022 5.87 5.78 6.03
5.59
876.98K 7.71% Aug 1, 2022 5.45 5.75 5.78
5.29
2.32M -5.55% Jul 29, 2022 5.77 6.09 6.09
5.70
862.23K -4.31% Jul 28, 2022 6.03 6.15 6.17
5.85
347.85K -1.63% Jul 27, 2022 6.13 6.15 6.18
5.96
390.68K 0.49% Jul 26, 2022 6.10 6.23 6.35
5.93
523.02K -2.56% Jul 25, 2022 6.26 6.19 6.29
6.10
411.19K 0.81% Jul 22, 2022 6.21 6.45 6.47
6.20
350.67K -3.72% Jul 21, 2022 6.45 6.51 6.53
6.33
413.03K -1.98% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1998 Employees:479 News
Esperions stock tumbles after disclosing dispute about milestone payment finance.yahoo.com Mar 16, 2023 8:21 am
2 Biotech Stocks Options Traders Are Watching finance.yahoo.com Mar 8, 2023 1:36 pm
International Lipid Expert Panel (ILEP) Recommends Use of Bempedoic Acid Ahead of PCSK9 Inhibitors in Managing Lipid Disorders and Cardiovascular Risk finance.yahoo.com Mar 8, 2023 8:00 am
China stocks slip after growth target released, as Ciena shares pop on earnings beat finance.yahoo.com Mar 8, 2023 7:45 am Esperion Therapeutics GAAP EPS of -$0.76 beats by $0.09, revenue of $18.8M misses by $1.8M seekingalpha.com Feb 21, 2023 8:01 pm Esperion Therapeutics Q4 2022 Earnings Preview seekingalpha.com Feb 20, 2023 11:25 pm
Esperion Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update finance.yahoo.com Mar 8, 2023 7:00 am
Esperion Therapeutics Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag finance.yahoo.com Mar 8, 2023 5:41 am
Landmark CLEAR Outcomes Study Demonstrates NEXLETOL® (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population of Both Primary Prevention and Secondary Prevention Patients finance.yahoo.com Mar 4, 2023 10:30 am
CLEAR Outcomes Company Update Call: Detailed Results Discussion finance.yahoo.com Feb 27, 2023 8:00 am
Need To Know: The Consensus Just Cut Its Esperion Therapeutics, Inc. (NASDAQ:ESPR) Estimates For 2023 finance.yahoo.com Feb 27, 2023 5:57 am
Esperion Launches New Scientific Website finance.yahoo.com Feb 24, 2023 1:40 pm
Esperion to Participate in the Cowen 43rd Annual Healthcare Conference finance.yahoo.com Feb 23, 2023 8:00 am
Esperion (ESPR) Q4 Loss Narrows, Revenues Miss, Stock Down finance.yahoo.com Feb 22, 2023 9:06 am
Esperion Therapeutics (ESPR) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com Feb 21, 2023 8:25 am
Esperion Announces Positive CLEAR Outcomes Results To Be Presented as Late-Breaking Clinical Trial at ACC.23/WCC finance.yahoo.com Feb 20, 2023 8:00 am
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) finance.yahoo.com Feb 13, 2023 4:30 pm
Esperion to Report Fourth Quarter and Full Year 2022 Financial Results February 21, 2023 finance.yahoo.com Feb 7, 2023 8:00 am
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year? finance.yahoo.com Feb 6, 2023 9:40 am
Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint finance.yahoo.com Feb 6, 2023 8:05 am This company doesn't provide a dividend.
Key Persons CEO : Sheldon Koenig Chief Medical Officer : Jo Anne Foody Talk about Esperion Therapeutics Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?